Stay updated on Vopratelimab Combinations in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Vopratelimab Combinations in Solid Tumors Clinical Trial page.

Latest updates to the Vopratelimab Combinations in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocation sections were reorganized into a single 'Locations' section with Missouri, Texas, and Virginia listed, replacing the separate 'Missouri Locations', 'Texas Locations', and 'Virginia Locations' subsections.SummaryDifference0.4%

- Check53 days agoChange DetectedThis page update is a minor metadata revision to v3.3.2, replacing v3.2.0 without changes to study information or participant details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedNotice about government funding/status at the top of the page has been removed, with no change to trial content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedThe new screenshot indicates termination of sponsor-provided vopratelimab treatment for long-term participants. It also shows updates to enrollment and completion details.SummaryDifference0.5%

- Check104 days agoChange DetectedMajor update: adds a government operating status notice and bumps version to v3.2.0, removing the old v3.1.0 tag.SummaryDifference5%

Stay in the know with updates to Vopratelimab Combinations in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vopratelimab Combinations in Solid Tumors Clinical Trial page.